Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

OV962

Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores
Unstained: $185.00 Add to Cart
H&E (OV962s*): $185.00 Add to Cart

Microarray Panel:Ovarian tumor tissue microarray, containing 21 cases of ovary adenocarcinoma, 12 ovary endometrioid adenocarcinoma, 1 each of ovary undifferentiated carcinoma and Krukenberg tumor, 2 each of ovary disgerminoma, endodermal sinus carcinoma and granular cell tumor, 5 ovary theca cell tumor, plus 2 adjacent normal ovary tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
B Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
C Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
D Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
E Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
F Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
G Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
H Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Marked point
Legend: Ova - Ovary

- Malignant tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Metastasis, - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 37 Ovary Serous papillary adenocarcinoma 1 Ic T1cN0M0 Malignant
A2 2 F 56 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
A3 3 F 37 Ovary Serous papillary adenocarcinoma 1 I T1N0M0 Malignant
A4 4 F 55 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
A5 5 F 39 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
A6 6 F 53 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
A7 7 F 54 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
A8 8 F 60 Ovary Adenocarcinoma (sparse) – Ib T1bN0M0 Malignant
A9 9 F 50 Ovary Serous adenocarcinoma 3 Ic T1cN0M0 Malignant
A10 10 F 52 Ovary Serous adenocarcinoma 3 Ia T1aN0M0 Malignant
A11 11 F 63 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
A12 12 F 46 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
B1 13 F 37 Ovary Serous papillary adenocarcinoma 1 Ic T1cN0M0 Malignant
B2 14 F 56 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
B3 15 F 37 Ovary Serous papillary adenocarcinoma 1 I T1N0M0 Malignant
B4 16 F 55 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
B5 17 F 39 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
B6 18 F 53 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
B7 19 F 54 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
B8 20 F 60 Ovary Serous adenocarcinoma 3 Ib T1bN0M0 Malignant
B9 21 F 50 Ovary Serous adenocarcinoma 3 Ic T1cN0M0 Malignant
B10 22 F 52 Ovary Serous adenocarcinoma 3 Ia T1aN0M0 Malignant
B11 23 F 63 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B12 24 F 46 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
C1 25 F 42 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
C2 26 F 46 Ovary Mucinous papillary adenocarcinoma 2 I T1N0M0 Malignant
C3 27 F 54 Ovary Mucinous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
C4 28 F 39 Ovary Mucinous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
C5 29 F 49 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
C6 30 F 64 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
C7 31 F 67 Ovary Mucinous papillary adenocarcinoma 2 I T1N0M0 Malignant
C8 32 F 37 Ovary Mucinous papillary adenocarcinoma 2–3 I T1N0M0 Malignant
C9 33 F 40 Ovary Mucinous papillary adenocarcinoma 2–3 Ic T1cN0M0 Malignant
C10 34 F 65 Ovary Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
C11 35 F 54 Ovary Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
C12 36 F 40 Ovary Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
D1 37 F 42 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
D2 38 F 46 Ovary Mucinous papillary adenocarcinoma 2 I T1N0M0 Malignant
D3 39 F 54 Ovary Mucinous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
D4 40 F 39 Ovary Mucinous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
D5 41 F 49 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
D6 42 F 64 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
D7 43 F 67 Ovary Mucinous papillary adenocarcinoma 2 I T1N0M0 Malignant
D8 44 F 37 Ovary Mucinous papillary adenocarcinoma 2–3 I T1N0M0 Malignant
D9 45 F 40 Ovary Mucinous papillary adenocarcinoma 2–3 Ic T1cN0M0 Malignant
D10 46 F 65 Ovary Endometrioid adenocarcinoma with necrosis (sparse) 1 Ic T1cN0M0 Malignant
D11 47 F 54 Ovary Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
D12 48 F 40 Ovary Endometrioid adenocarcinoma with necrosis 2 Ia T1aN0M0 Malignant
E1 49 F 69 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
E2 50 F 49 Ovary Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
E3 51 F 43 Ovary Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
E4 52 F 62 Ovary Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
E5 53 F 64 Ovary Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
E6 54 F 45 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
E7 55 F 55 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
E8 56 F 75 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
E9 57 F 33 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
E10 58 F 24 Ovary Undifferentiated carcinoma – Ia T1aN0M0 Malignant
E11 59 F 18 Ovary Disgerminoma – Ia T1aN0M0 Malignant
E12 60 F 49 Ovary Disgerminoma – Ib T1bN0M0 Malignant
F1 61 F 69 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
F2 62 F 49 Ovary Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
F3 63 F 43 Ovary Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F4 64 F 62 Ovary Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
F5 65 F 64 Ovary Endometrioid adenocarcinoma 3 Ia T1aN0M0 Malignant
F6 66 F 45 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
F7 67 F 55 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
F8 68 F 75 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
F9 69 F 33 Ovary Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
F10 70 F 24 Ovary Undifferentiated carcinoma (sparse) – Ia T1aN0M0 Malignant
F11 71 F 18 Ovary Disgerminoma – Ia T1aN0M0 Malignant
F12 72 F 49 Ovary Disgerminoma – Ib T1bN0M0 Malignant
G1 73 F 25 Ovary Endodermal sinus carcinoma (sparse) – Ib T1bN0M0 Malignant
G2 74 F 15 Ovary Endodermal sinus carcinoma – Ib T1bN0M0 Malignant
G3 75 F 38 Ovary Krukenberg tumor – – – Metastasis
G4 76 F 42 Ovary Granular cell tumor – – – Malignant
G5 77 F 57 Ovary Granular cell tumor – – – Malignant
G6 78 F 47 Ovary Theca cell tumor – – – Malignant
G7 79 F 62 Ovary Theca cell tumor – – – Malignant
G8 80 F 62 Ovary Theca cell tumor – – – Malignant
G9 81 F 70 Ovary Theca cell tumor – – – Malignant
G10 82 F 65 Ovary Theca cell tumor – – – Malignant
G11 83 F 33 Ovary Cancer adjacent normal ovary tissue – – – NAT
G12 84 F 42 Ovary Cancer adjacent normal ovary tissue – – – NAT
H1 85 F 25 Ovary Endodermal sinus carcinoma (sparse) – Ib T1bN0M0 Malignant
H2 86 F 15 Ovary Endodermal sinus carcinoma – Ib T1bN0M0 Malignant
H3 87 F 38 Ovary Krukenberg tumor – – – Metastasis
H4 88 F 42 Ovary Granular cell tumor – – – Malignant
H5 89 F 57 Ovary Granular cell tumor – – – Malignant
H6 90 F 47 Ovary Theca cell tumor – – – Malignant
H7 91 F 62 Ovary Theca cell tumor – – – Malignant
H8 92 F 62 Ovary Theca cell tumor – – – Malignant
H9 93 F 70 Ovary Theca cell tumor – – – Malignant
H10 94 F 65 Ovary Theca cell tumor – – – Malignant
H11 95 F 33 Ovary Cancer adjacent normal ovary tissue – – – NAT
H12 96 F 42 Ovary Cancer adjacent normal ovary tissue – – – NAT
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal